Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density
NCT03199963Phase 3Terminated
- Sponsor
- BHR Pharmaceuticals
- Start
- Aug 2017
- Primary completion
- Jan 2019
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of afimoxifene, sponsored by BHR Pharmaceuticals. Started Aug 2017; status: terminated.
02
Drugs
afimoxifene
Beyond the preview
Go deeper on NCT03199963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03199963.